Betnovate S Information
Betnovate S is a prescription drug, available for use as Ointment. Other than this, Betnovate S has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Betnovate S. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Common side effects of Betnovate S include Skin Rash. Besides the aforementioned side effects, there are other adverse effects of Betnovate S as well, which are listed below. Such side effects of Betnovate S normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Betnovate S's effect is Unknown during pregnancy and Unknown for lactating mothers. In addition, Betnovate S's effects on the liver, heart and kidney are discussed below in the Betnovate S related warnings section.
Betnovate S can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Betnovate S in conditions like Liver Disease, Scleroderma, Tuberculosis (TB). Other conditions have been mentioned below in the Betnovate S contraindications section.
Drug reaction of Betnovate S with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Betnovate S, it is important to know that it is safe while driving, and is habit-forming.
Betnovate S Benefits & Uses
Betnovate S is used to treat the following -
Other Benefits
Betnovate S Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Betnovate S Related Warnings
-
Is the use of Betnovate S safe for pregnant women?
The effects of Betnovate S on pregnant women are unknown since no research has been done to ascertain it yet.
-
Is the use of Betnovate S safe during breastfeeding?
In the absence of any scientific study about the side effects of Betnovate S in breastfeeding women, information on safety of Betnovate S is unavailable.
-
What is the effect of Betnovate S on the Kidneys?
Betnovate S rarely affects the kidneys.
-
What is the effect of Betnovate S on the Liver?
Betnovate S does not damage the liver.
-
What is the effect of Betnovate S on the Heart?
Betnovate S has very mild side effects on the heart.
Severe Interaction of Betnovate S with Other Drugs
Betnovate S should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
- Wheezal Diabonol Drop
- Huminsulin R 100 IU/ml Cartridge
- Huminsulin R 100 IU/ml Injection
- Insuman Rapid 100 Solution for Injection
Mild
Betnovate S Contraindications
If you are suffering from any of the following diseases, you should not take Betnovate S unless your doctor advises you to do so -
- Allergy
- Liver Disease
- Infections
- Scleroderma
- Dehydration
- Tuberculosis (TB)
- Diabetes
- Diaper Rash
- Heart Disease
- Depression
- Crohn's Disease
- Peripheral Vascular Disease (PVD)
- Diabetes
- Liver Disease
- Kidney Disease
Frequently asked Questions about Betnovate S
-
Is this Betnovate S habit forming or addictive?
Betnovate S is not addictive in nature.
Betnovate S Interactions with Food and Alcohol
-
Interaction between Food and Betnovate S
There isn't any research available on the side effects of taking Betnovate S with food.
-
Interaction between Alcohol and Betnovate S
It is difficult to say anything about the effect of Betnovate S and alcohol. No research has been done on this yet.
See all substitutes for Betnovate S
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 889